Kristagen is a next-generation thymus-targeting dipeptide bioregulator designed to restore and maintain immune function through epigenetic modulation of T-cell development pathways.
Research Applications
Immune restoration, thymic function, age-related immune decline, and T-cell maturation support.
Dosage Information (Research Use)
Capsules: 1-2 daily for 10-30 day courses. Research use only.
Reconstitution & Handling
Capsules taken orally. Injectable: standard reconstitution.
Half-Life & Pharmacokinetics
Short.
Reported Observations in Literature
Generally well-tolerated.
Key Research References
- Khavinson VK. “Short peptides modulate immune function.” Bull Exp Biol Med. 2010